# Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026
Canonical URL: https://biopharmsignal.com/news/PSNL/personalis-and-collaborators-to-highlight-ultrasensitive-ctdna-data-and-new-therapy-resistance-tracking-capabilities-at-aacr-2026
Ticker: PSNL
Company: Personalis
Source: Personalis
Published: 2026-04-13 10:00 EST
Original Source URL: https://investors.personalis.com
## Summary

Oral podium presentation to highlight NeXT Personal ® in colorectal cancer; Personalis to debut first data for Real-Time Variant Tracker ™ to monitor therapy resistance during NeXT Personal MRD testing FREMONT, Calif. --(BUSINESS WIRE)--Apr. 13, 2026-- Personalis, Inc.

## Article Body
Oral podium presentation to highlight NeXT Personal ® in colorectal cancer; Personalis to debut first data for Real-Time Variant Tracker ™ to monitor therapy resistance during NeXT Personal MRD testing FREMONT, Calif. --(BUSINESS WIRE)--Apr. 13, 2026-- Personalis, Inc.
## Recent Company News
- 2026-06-02 10:00 EST — [Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026](https://biopharmsignal.com/news/PSNL/personalis-highlights-early-colorectal-cancer-recurrence-detection-and-ultrasensitive-mrd-performance-across-a-broad-set-of-tumor-types-at-asco-2026) — Source: Personalis
- 2026-05-26 10:00 EST — [Personalis to Highlight Breadth of NeXT Personal® Ultra-Sensitive ctDNA Data at ASCO 2026 Annual Meeting, Including Podium Presentation from TRACERx Consortium](https://biopharmsignal.com/news/PSNL/personalis-to-highlight-breadth-of-next-personalr-ultra-sensitive-ctdna-data-at-asco-2026-annual-meeting-including-podium-presentation-from-tracerx-consortium) — Source: Personalis
- 2026-05-20 10:00 EST — [Personalis Secures Fourth Medicare Coverage Decision for NeXT Personal®, Expanding Breast Cancer Coverage to Pre-Surgical Treatment Monitoring](https://biopharmsignal.com/news/PSNL/personalis-secures-fourth-medicare-coverage-decision-for-next-personalr-expanding-breast-cancer-coverage-to-pre-surgical-treatment-monitoring) — Source: Personalis
- 2026-05-14 20:01 EST — [Personalis to Participate in Upcoming Investor Events](https://biopharmsignal.com/news/PSNL/personalis-to-participate-in-upcoming-investor-events) — Source: Personalis
- 2026-05-13 10:00 EST — [Personalis Receives Medicare Coverage for NeXT Personal® for Immunotherapy Monitoring Across Late-stage Solid Tumors](https://biopharmsignal.com/news/PSNL/personalis-receives-medicare-coverage-for-next-personalr-for-immunotherapy-monitoring-across-late-stage-solid-tumors) — Source: Personalis
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)